On August 30, 2026, leading healthcare policy coordinators published a comparative guide on oncology procurement pathways. Patients seeking personal supplies and clinics seeking bulk quantities face different logistical, regulatory, and cost requirements. Sourcing the correct procurement option is crucial to ensure patient therapy timeline matches supply lead time.

At Onco Medicine, we support both individual patient personal imports and institutional bulk supplies, maintaining strict compliance with FDA and WHO guidelines.

Comparing Sourcing Options

Understanding the key differences between patient personal orders and hospital bulk supply:

• Patient Personal Import: Sourced under personal import exemptions (like FDA Personal Importation Policy or TGA scheme). Strictly limited to a 90-day supply, requiring an individual prescription matching the patient's name.
• Hospital Bulk Supply: Managed under wholesale distribution licenses or Ministry of Health special permits. Allows procurement of larger batches for clinical reserves, requiring clinical registrations and batch trace files.

For custom consultations, email our desk at support@onco-medicine.com or WhatsApp WhatsApp +91 94275 19809.